Children with PWS have low insulin-like growth factor I (IGF-I) levels prior to treatment with growth hormone (GH) [6] and might have decreased GH secretion after provocative testing [7], which contributes to short stature, increased fat mass, and decreased lean body mass in PWS. Here, GH1 is linked to Prader-Willi syndrome.